Novartis AG (0QLR) Stock Statistics & Valuation Metrics
Total Valuation
Novartis AG has a market cap or net worth of CHF 244.89B. The enterprise value is CHF 261.65B.
- Market Cap
- CHF 244.89B
- Enterprise Value
- CHF 261.65B
Share Statistics
Novartis AG has 2,034,819,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,034,819,500
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Novartis AG’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is 16.17%.
- Return on Equity (ROE)
- 0.32
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 16.17%
- Return on Capital Employed (ROCE)
- 0.20
- Revenue Per Employee
- 758.98K
- Profits Per Employee
- 194.63K
- Employee Count
- 75,267
- Asset Turnover
- 0.49
- Inventory Turnover
- 2.28
Valuation Ratios
The current PE Ratio of Novartis AG is 31.19. Novartis AG’s PEG ratio is -1.07.
- PE Ratio
- 31.19
- PS Ratio
- 5.57
- PB Ratio
- 8.22
- Price to FCF
- 19.97
- Price to Operating Cash Flow
- 18.08
- PEG Ratio
- -1.07
Income Statement
In the last 12 months, Novartis AG had revenue of 57.13B and earned 14.65B in profits. Earnings per share was 7.56.
- Revenue
- 57.13B
- Gross Profit
- 42.86B
- Operating Income
- 17.80B
- Pretax Income
- 17.13B
- Net Income
- 14.65B
- EBITDA
- 23.96B
- Earnings Per Share (EPS)
- 7.56
Cash Flow
In the last 12 months, operating cash flow was 17.01B and capital expenditures -1.67B, giving a free cash flow of 15.34B billion.
- Operating Cash Flow
- 17.01B
- Free Cash Flow
- 15.34B
- Free Cash Flow per Share
- 8.09
Dividends & Yields
Novartis AG pays an annual dividend of ―, resulting in a dividend yield of 2.76%
- Dividend Per Share
- ―
- Dividend Yield
- 2.76%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.01%
- Earnings Yield
- 3.23%
Stock Price Statistics
- Beta
- 1.04
- 52-Week Price Change
- 36.08%
- 50-Day Moving Average
- 121.56
- 200-Day Moving Average
- 120.82
- Relative Strength Index (RSI)
- 73.84
- Average Volume (3m)
- 944.34K
Important Dates
Novartis AG upcoming earnings date is Feb 03, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Novartis AG as a current ratio of 1.12, with Debt / Equity ratio of 80.28%
- Current Ratio
- 1.12
- Quick Ratio
- 0.89
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 1.07
- Interest Coverage Ratio
- 14.38
Taxes
In the past 12 months, Novartis AG has paid 2.50B in taxes.
- Income Tax
- 2.50B
- Effective Tax Rate
- 0.15
Enterprise Valuation
Novartis AG EV to EBITDA ratio is 15.39, with an EV/FCF ratio of 22.55.
- EV to Sales
- 6.29
- EV to EBITDA
- 15.39
- EV to Free Cash Flow
- 22.55
- EV to Operating Cash Flow
- 20.34
Balance Sheet
Novartis AG has CHF 9.02B in cash and marketable securities with CHF 48.53B in debt, giving a net cash position of -CHF 39.51B billion.
- Cash & Marketable Securities
- CHF 9.02B
- Total Debt
- CHF 48.53B
- Net Cash
- -CHF 39.51B
- Net Cash Per Share
- -CHF 19.42
- Tangible Book Value Per Share
- -CHF 15.60
Margins
Gross margin is 74.30%, with operating margin of 30.47%, and net profit margin of 18.06%.
- Gross Margin
- 74.30%
- Operating Margin
- 30.47%
- Pretax Margin
- 22.77%
- Net Profit Margin
- 18.06%
- EBITDA Margin
- 40.89%
- EBIT Margin
- 31.26%
Analyst Forecast
The average price target for Novartis AG is CHF 125.93, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- CHF 125.93
- Price Target Upside
- 6.05% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 14
- Revenue Growth Forecast
- -4.48%
- EPS Growth Forecast
- -33.14%